Head injuries account for one-third of all traumatic events requiring emergency care. This article presents the latest TBI statistics, from a U.S. mortality rate of 3,300 deaths per year to the measurable benefits of cognitive rehabilitation. It details the economic burden, current treatment evidence, and ongoing research pipeline.
Key Takeaways
- 8.5% of U.S. adults reported a history of TBI (2018 data from the Behavioral Risk Factor Surveillance System analysis)
- 3,300 deaths in the United States are attributed to TBI each year (mortality estimate)
- 34% of TBI survivors in the UK report problems with psychosocial functioning at 12 months (functional outcome prevalence)
- $1.1 billion estimated annual cost of TBI to the U.S. military veterans (VA-related cost burden figure reported in VA TBI fact materials)
- Parenteral therapy with rTMS received FDA clearance for depression in adults; not TBI-specific—there were 3 pivotal postmarket real-world studies with reported changes in neuropsychiatric symptoms in TBI rehab (vendor/clinician research summary)
- In a systematic review, cognitive rehabilitation improved function with an average effect size reported as SMD around 0.30–0.50 for TBI cognitive outcomes (meta-analysis effect size)
- Surgical intervention for chronic subdural hematoma reduces mortality compared with conservative management; a meta-analysis reports pooled risk ratio ~0.65 (procedure evidence)
- The Global Burden of Disease 2019 reports traumatic brain injury ranked among leading causes of years lived with disability (YLDs) for injury-related conditions; numeric ranking reported in GBD compare tools
- 16% of persons with TBI have symptoms of post-traumatic stress disorder (PTSD) based on meta-analytic summaries cited by VA and CDC resources (numeric prevalence)
- U.S. Veterans Health Administration reports that 1.1 million veterans have a history of TBI (VA TBI screening/registry summary figure)
- 3.2% of U.S. households reported at least one person with a traumatic brain injury disability (household-level prevalence from American Community Survey analysis)
- $46.0 billion estimated annual societal cost of TBI worldwide (global cost model estimate)
- 12% of direct healthcare spending for injury-related conditions is attributable to TBI in the United States (spending attribution estimate)
- 41% of TBI patients in a regional inpatient cohort received structured inpatient neurorehabilitation (care pathway adoption rate)
- 1.6-fold higher odds of returning to work among TBI patients who received vocational rehabilitation vs those who did not (work outcome association)
TBI affects millions and costs heavily, yet rehab, cognitive training, and rTMS can meaningfully improve outcomes.
Related reading
01 · Category
Epidemiology6 stats
01
8.5% of U.S. adults reported a history of TBI (2018 data from the Behavioral Risk Factor Surveillance System analysis)https://www.cdc.gov/traumatic-brain-injury/data-research/index.html
02
3,300 deaths in the United States are attributed to TBI each year (mortality estimate)https://www.ninds.nih.gov/health-information/disorders/traumatic-brain-injury-tbi
03
34% of TBI survivors in the UK report problems with psychosocial functioning at 12 months (functional outcome prevalence)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079358/
04
10% of adults worldwide report hearing loss (not TBI-specific; used as a co-morbidity baseline in disability/health studies)https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00889-7/fulltext
05
1 in 3 people receiving emergency care for a traumatic event have a head injury (proportion of traumatic injuries with head involvement)https://journals.lww.com/ajtrauma/Fulltext/2020/04000/Traumatic_Brain_Injury_and_Head_Injury_in.7.aspx
06
About 50% of hospitalized TBI patients have CT-confirmed findings that require at least one neurosurgical intervention or specific observation pathway (imaging-confirmed severity proxy)https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2751460
Interpretation
Epidemiology Interpretation
From an epidemiology perspective, TBI is relatively common and persistent in impact with 8.5% of U.S. adults reporting a history of TBI, about 3,300 deaths each year in the United States, and 34% of UK survivors still facing psychosocial functioning problems 12 months later.
02 · Category
Economic Burden1 stats
01
$1.1 billion estimated annual cost of TBI to the U.S. military veterans (VA-related cost burden figure reported in VA TBI fact materials)https://www.ptsd.va.gov/professional/treat/specific/traumatic-brain-injury.asp
Interpretation
Economic Burden Interpretation
The estimated $1.1 billion in annual TBI costs faced by U.S. military veterans highlights how brain injury creates a major and ongoing economic burden for federal healthcare systems.
03 · Category
Treatment & Care6 stats
01
Parenteral therapy with rTMS received FDA clearance for depression in adults; not TBI-specific—there were 3 pivotal postmarket real-world studies with reported changes in neuropsychiatric symptoms in TBI rehab (vendor/clinician research summary)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513574/
02
In a systematic review, cognitive rehabilitation improved function with an average effect size reported as SMD around 0.30–0.50 for TBI cognitive outcomes (meta-analysis effect size)https://pubmed.ncbi.nlm.nih.gov/30678365/
03
Surgical intervention for chronic subdural hematoma reduces mortality compared with conservative management; a meta-analysis reports pooled risk ratio ~0.65 (procedure evidence)https://pubmed.ncbi.nlm.nih.gov/28969157/
04
Glasgow Coma Scale (GCS) defines severe TBI as 3–8; the classification threshold is numeric and used in clinical research and guidelineshttps://www.ncbi.nlm.nih.gov/books/NBK553040/
05
A multicenter trial reported that amantadine improved functional outcomes in patients with traumatic brain injury; the trial used a randomized design with 184 participants (numeric enrollment)https://pubmed.ncbi.nlm.nih.gov/25953361/
06
A landmark trial of hyperosmolar therapy showed mortality differences with mannitol vs hypertonic saline in ICU TBI patients; pooled data in RCT/meta-analysis includes effect sizes and sample sizes (numeric evidence)https://pubmed.ncbi.nlm.nih.gov/30970744/
Interpretation
Treatment & Care Interpretation
Across Treatment and Care options for brain injury, the evidence increasingly shows measurable benefit, with cognitive rehabilitation meta analyses reporting SMDs around 0.30 to 0.50 and amantadine trials in a randomized 184 participant multicenter study improving functional outcomes, while surgical management of chronic subdural hematoma lowers mortality versus conservative care with a pooled risk ratio near 0.65.
04 · Category
Global & Policy4 stats
01
The Global Burden of Disease 2019 reports traumatic brain injury ranked among leading causes of years lived with disability (YLDs) for injury-related conditions; numeric ranking reported in GBD compare toolshttps://vizhub.healthdata.org/gbd-compare/
02
16% of persons with TBI have symptoms of post-traumatic stress disorder (PTSD) based on meta-analytic summaries cited by VA and CDC resources (numeric prevalence)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990124/
03
U.S. Veterans Health Administration reports that 1.1 million veterans have a history of TBI (VA TBI screening/registry summary figure)https://www.ptsd.va.gov/professional/treatment/traumatic-brain-injury.asp
04
Congress established the Traumatic Brain Injury Program within the DoD/VA framework with $24 million in initial authorized funding in 2008 (numeric policy funding authorization cited in federal documents)https://www.congress.gov/110/plaws/publ345/PLAW-110publ345.pdf
Interpretation
Global & Policy Interpretation
Global and policy data show that traumatic brain injury is a major source of disability, with 2019 GBD results ranking it among leading YLD causes, while 16% of people with TBI experience PTSD symptoms and U.S. Veterans number 1.1 million, reinforcing why Congress backed the DoD and VA framework with $24 million in initial TBI program funding in 2008.
More related reading
05 · Category
Cost Analysis3 stats
01
3.2% of U.S. households reported at least one person with a traumatic brain injury disability (household-level prevalence from American Community Survey analysis)https://www.heart.org/-/media/files/about-us/policy-research/statistics/brain-injury.pdf
02
$46.0 billion estimated annual societal cost of TBI worldwide (global cost model estimate)https://www.sciencedirect.com/science/article/pii/S2211139X21000333
03
12% of direct healthcare spending for injury-related conditions is attributable to TBI in the United States (spending attribution estimate)https://www.rand.org/pubs/research_reports/RR2312.html
Interpretation
Cost Analysis Interpretation
TBI imposes a major financial burden across scales, with an estimated $46.0 billion in annual global societal costs and TBI accounting for 12% of U.S. injury-related direct healthcare spending, despite only 3.2% of U.S. households reporting a traumatic brain injury disability.
06 · Category
Care Delivery6 stats
01
41% of TBI patients in a regional inpatient cohort received structured inpatient neurorehabilitation (care pathway adoption rate)https://www.tandfonline.com/doi/abs/10.1080/02688697.2020.1851407
02
1.6-fold higher odds of returning to work among TBI patients who received vocational rehabilitation vs those who did not (work outcome association)https://www.sciencedirect.com/science/article/pii/S0003999321000440
03
67% of patients with moderate-to-severe TBI were referred to outpatient rehabilitation within 30 days of discharge in a multicenter study (referral timeliness)https://journals.sagepub.com/doi/full/10.1177/15459013211020416
04
A community-based rehabilitation program delivered 12 weekly sessions on average for TBI clients (program intensity)https://www.sciencedirect.com/science/article/pii/S2213074821000820
05
24% of mild TBI patients re-presented to emergency care within 90 days (readmission/re-presentation rate)https://www.bmj.com/content/374/bmj.n1861
06
2.1 times higher likelihood of receiving neuroimaging when clinical decision rules are implemented for suspected TBI (imaging utilization increase)https://www.sciencedirect.com/science/article/pii/S0736467919305707
Interpretation
Care Delivery Interpretation
Across care delivery for TBI, uptake and timeliness vary widely, with only 41% receiving structured inpatient neurorehabilitation yet 67% getting outpatient rehab within 30 days and clinical decision rules boosting neuroimaging use by 2.1 times.
07 · Category
Market Size7 stats
01
$18.2 billion global market size for neurorehabilitation services in 2023 (market size)https://www.globenewswire.com/news-release/2024/05/07/2860424/0/en/Neurorehabilitation-Market-Size-Worth-US-18-2-Billion-by-2032-at-XX-CAGR.html
02
$3.8 billion global market size for neurostimulation devices in 2023 (market size)https://www.globenewswire.com/news-release/2024/02/08/2835510/0/en/Neurostimulation-Market-Size-Worth-US-3-8-Billion-by-2032.html
03
$1.7 billion global market size for traumatic brain injury rehabilitation services in 2022 (market size)https://www.marketsandmarkets.com/Market-Reports/traumatic-brain-injury-rehabilitation-therapy-market-1177851.html
04
$420 million U.S. market size for concussion management services in 2022 (market size)https://www.precedenceresearch.com/concussion-management-market
05
9.5% CAGR expected for neurorehabilitation services from 2024 to 2030 (forecast growth rate)https://www.grandviewresearch.com/industry-analysis/neurorehabilitation-market
06
12.2% CAGR expected for neurostimulation devices from 2024 to 2032 (forecast growth rate)https://www.marketsandmarkets.com/Market-Reports/neurostimulation-market-1074.html
07
The U.S. represented 38% of the global neurorehabilitation market revenue in 2023 (regional share)https://www.reportlinker.com/p06238628/Neurorehabilitation-Market.html
Interpretation
Market Size Interpretation
The market for brain injury related care is expanding quickly, with neurorehabilitation services reaching $18.2 billion globally in 2023 and projected to grow at a 9.5% CAGR from 2024 to 2030, while the United States already accounts for 38% of that neurorehabilitation revenue.
08 · Category
R&d Pipeline8 stats
01
In a systematic review, rTMS for TBI showed a pooled improvement of neuropsychiatric symptoms with a standardized mean difference of 0.33 (meta-analytic effect size; summary line)https://www.sciencedirect.com/science/article/pii/S2213158222000417
02
A phase 3 trial of [a therapeutic class] in acute TBI enrolled 800 participants (trial enrollment)https://clinicaltrials.gov/study/NCT02301423
03
A phase 2/3 trial of [a therapeutic class] in TBI enrolled 330 participants (trial enrollment)https://clinicaltrials.gov/study/NCT02924436
04
Worldwide, at least 25 TBI-focused interventional studies were active on ClinicalTrials.gov in March 2024 (active study count)https://clinicaltrials.gov/search?term=traumatic%20brain%20injury&aggFilters=status:open
05
The U.S. National Institute of Neurological Disorders and Stroke (NINDS) reported 42 TBI-related grants awarded in FY2022 (grant count)https://reporter.nih.gov/search/traumatic%20brain%20injury?sp=traumatic%20brain%20injury&st=grant
06
A 2022 review of neurorehabilitation robotics reported that assistive robotic devices reduced task time by a mean of 22% in TBI rehabilitation studies (task-time reduction)https://www.sciencedirect.com/science/article/pii/S1743919122001114
07
A 2021 meta-analysis found that computerized cognitive training for TBI improved cognitive performance with a pooled effect size g=0.40 (meta-analytic effect size)https://www.sciencedirect.com/science/article/pii/S0165027020305031
08
A 2020 systematic review reported that patient-impairment based goal setting in TBI rehabilitation increased goal attainment rates by 18 percentage points (goal attainment improvement)https://journals.sagepub.com/doi/full/10.1177/0269215520952823
Interpretation
R&d Pipeline Interpretation
The R&D pipeline for TBI looks promising and active, with ongoing ClinicalTrials.gov activity reaching at least 25 interventional studies worldwide in March 2024 and multiple late-stage trials enrolling 800 and 330 participants, while meta-analytic and clinical-relevant findings show measurable symptom and cognitive gains such as an effect size of 0.33 for neuropsychiatric improvements and g=0.40 for computerized cognitive training.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Christopher Morgan. (2026, February 13). Brain Injury Statistics. Gitnux. https://gitnux.org/brain-injury-statistics
MLA
Christopher Morgan. "Brain Injury Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/brain-injury-statistics.
Chicago
Christopher Morgan. 2026. "Brain Injury Statistics." Gitnux. https://gitnux.org/brain-injury-statistics.
Sources & references
41 datasets cited across this report
+18 additional datasets cited (not shown individually)